Annual Current Liabilities
$11.55 M
+$2.49 M+27.48%
December 31, 2023
Summary
- As of February 23, 2025, ATXS annual total current liabilities is $11.55 million, with the most recent change of +$2.49 million (+27.48%) on December 31, 2023.
- During the last 3 years, ATXS annual current liabilities has risen by +$5.16 million (+80.75%).
- ATXS annual current liabilities is now at all-time high.
Performance
ATXS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$15.72 M
-$644.00 K-3.93%
September 30, 2024
Summary
- As of February 23, 2025, ATXS quarterly total current liabilities is $15.72 million, with the most recent change of -$644.00 thousand (-3.93%) on September 30, 2024.
- Over the past year, ATXS quarterly current liabilities has increased by +$6.34 million (+67.60%).
- ATXS quarterly current liabilities is now -3.93% below its all-time high of $16.37 million, reached on June 30, 2024.
Performance
ATXS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ATXS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.5% | +67.6% |
| 3 y3 years | +80.8% | +67.6% |
| 5 y5 years | +176.9% | +67.6% |
ATXS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.0% | -3.9% | +216.6% |
| 5 y | 5-year | at high | +129.5% | -3.9% | +294.3% |
| alltime | all time | at high | +294.2% | -3.9% | +294.3% |
Astria Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.72 M(-3.9%) |
| Jun 2024 | - | $16.37 M(+47.8%) |
| Mar 2024 | - | $11.07 M(-4.1%) |
| Dec 2023 | $11.55 M(+27.5%) | $11.55 M(+23.1%) |
| Sep 2023 | - | $9.38 M(+42.2%) |
| Jun 2023 | - | $6.60 M(-1.1%) |
| Mar 2023 | - | $6.67 M(-26.3%) |
| Dec 2022 | $9.06 M(+74.1%) | $9.06 M(+40.7%) |
| Sep 2022 | - | $6.44 M(+23.3%) |
| Jun 2022 | - | $5.22 M(+5.2%) |
| Mar 2022 | - | $4.97 M(-4.5%) |
| Dec 2021 | $5.20 M(-18.6%) | $5.20 M(+10.7%) |
| Sep 2021 | - | $4.70 M(+17.9%) |
| Jun 2021 | - | $3.99 M(-9.5%) |
| Mar 2021 | - | $4.41 M(-31.0%) |
| Dec 2020 | $6.39 M(+27.0%) | $6.39 M(-8.5%) |
| Sep 2020 | - | $6.98 M(+26.7%) |
| Jun 2020 | - | $5.51 M(+20.0%) |
| Mar 2020 | - | $4.59 M(-8.8%) |
| Dec 2019 | $5.03 M | $5.03 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $5.56 M(+7.6%) |
| Jun 2019 | - | $5.17 M(+20.2%) |
| Mar 2019 | - | $4.30 M(+3.0%) |
| Dec 2018 | $4.17 M(-30.7%) | $4.17 M(+1.1%) |
| Sep 2018 | - | $4.13 M(-16.9%) |
| Jun 2018 | - | $4.96 M(-6.0%) |
| Mar 2018 | - | $5.28 M(-12.3%) |
| Dec 2017 | $6.02 M(-27.7%) | $6.02 M(-20.4%) |
| Sep 2017 | - | $7.56 M(-7.0%) |
| Jun 2017 | - | $8.13 M(+8.4%) |
| Mar 2017 | - | $7.50 M(-10.0%) |
| Dec 2016 | $8.32 M(+7.0%) | $8.32 M(-2.5%) |
| Sep 2016 | - | $8.54 M(+15.1%) |
| Jun 2016 | - | $7.42 M(-0.1%) |
| Mar 2016 | - | $7.43 M(-4.5%) |
| Dec 2015 | $7.78 M(+83.7%) | $7.78 M(+5.0%) |
| Sep 2015 | - | $7.41 M(+0.2%) |
| Jun 2015 | - | $7.39 M(+48.1%) |
| Mar 2015 | - | $4.99 M(+17.9%) |
| Dec 2014 | $4.23 M(+44.5%) | $4.23 M |
| Dec 2013 | $2.93 M | - |
FAQ
- What is Astria Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Astria Therapeutics?
- What is Astria Therapeutics annual current liabilities year-on-year change?
- What is Astria Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Astria Therapeutics?
- What is Astria Therapeutics quarterly current liabilities year-on-year change?
What is Astria Therapeutics annual total current liabilities?
The current annual current liabilities of ATXS is $11.55 M
What is the all time high annual current liabilities for Astria Therapeutics?
Astria Therapeutics all-time high annual total current liabilities is $11.55 M
What is Astria Therapeutics annual current liabilities year-on-year change?
Over the past year, ATXS annual total current liabilities has changed by +$2.49 M (+27.48%)
What is Astria Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ATXS is $15.72 M
What is the all time high quarterly current liabilities for Astria Therapeutics?
Astria Therapeutics all-time high quarterly total current liabilities is $16.37 M
What is Astria Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ATXS quarterly total current liabilities has changed by +$6.34 M (+67.60%)